Sage Therapeutics SAGE shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington's disease.
Sage Therapeutics is currently up 3.42% to a price of $45.09. Wednesday the stock has been traded at a volume of 393.70 thousand, about 67.2% of its recent 30-day volume average of 585.88 thousand.
The 50-day moving average price of Sage Therapeutics's stock was $45.56 when this article was published. The stock reached a high of $98.39 and a low of $39.77 in the past 52 weeks.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
